ConscienHealth - Latest News and Information
The American Heart Association released a nine‑point dietary guidance that emphasizes plant‑based protein, low‑fat dairy, and limiting saturated fat to 10 percent of calories. The plan contrasts with Health Secretary Robert F. Kennedy Jr.’s recent push for more red meat and whole‑milk consumption. AHA also advises against ultra‑processed foods, added sugars, excess salt, and any alcohol intake. While both the AHA and HHS claim alignment on “real food” principles, the guidance underscores a clear scientific stance on heart‑healthy eating.
The Lancet Commission introduced a new framework for diagnosing clinical obesity that emphasizes causal links between excess adiposity and disease. The Endocrine Society’s recent guidance pauses full endorsement, citing practical and equity concerns, especially the Commission’s exclusion of type 2...
Novo Nordisk issued a press release claiming its Wegovy (semaglutide) tablets outperform the newly approved orforglipron (Foundayo) tablets, basing the claim on a simulated treatment comparison to be presented at the Obesity Medicine Association meeting. The article warns that such...
A JAMA research letter examined the CMS BALANCE model, estimating that treating 550,000 to 3.6 million Medicare beneficiaries with semaglutide could generate savings sufficient to offset program costs. The study presented a range of possible budget outcomes and concluded that additional...
The FDA has approved Foundayo (orforglipron), the first non‑peptide oral GLP‑1 tablet for obesity. As a small‑molecule drug, it sidesteps the manufacturing complexities that plagued peptide injectables like semaglutide and tirzepatide. Daily oral dosing promises easier adherence compared with weekly...
A new analysis in the Journal of Global Metabolic Systems proposes that widespread use of GLP‑1 weight‑loss drugs could help reverse climate change. By reducing overall caloric demand, the model predicts lower livestock production, especially beef and dairy, leading to...
